Join/Renew Now

Zero Tolerance Anti-Doping Newsletter
Volume 3, Issue 1 - January  2006

In This Issue

Why Zero Tolerance?

USA Track & Field CEO Craig A. Masback and USATF President Bill Roe developed the plan in concert with the USATF Board of Directors in October 2003 by combining existing programs and USATF priorities with ambitious new initiatives. "Zero Tolerance" focuses on three goals: increasing efforts to catch and punish cheaters; expanding educational efforts and focusing the message on the theme that cheating is wrong and cheaters will be caught; and taking a more visible role on these issues.

IAAF Announces New ATUE Protocol for 2006

In response to an increase in the use of Beta-2 Agonists by athletes, the IAAF Council has endorsed a recommendation from the IAAF Medical and Anti-Doping Commission to require more detailed information from applicants who seek an exemption for the use of Beta-2 Agonists for asthma and/or exercise-induced asthma or exercise-induced bronchoconstriction, and/or other clinical respiratory diseases requiring specific treatment.

Applicants seeking the use of the four Beta-2 Agonists (formeterol, salbutamol, salmeterol and terbutaline) will be required to submit the following information:

  1. An IAAF Abbreviated TUE Application Form including detailed medical records. The application can be downloaded at
  2. Objective evidence of asthma and/or exercise-induced asthma or exercise-induced bronchoconstriction, and/or other clinical respiratory diseases requiring specific treatment through the provision of test results and supporting documentation as set forth in the provocation test results requirements. ALL TESTS MUST BE PERFORMED AFTER JANUARY 1, 2005.

The IAAF has also developed a Detailed Medical Records form that athletes can take to their physician to have them complete the form and control the amount of detailed medical records that are submitted to the IAAF. This application can be download at

For athletes who have well-controlled asthma with negative response to all the tests - the IAAF has acknowledged the exceptional cases of athletes with known, but well-controlled, asthma reporting 'negative' results from the bronchial provocation tests, while applying for the use of inhaled Beta-2 Agonists, the following documentation must be enclosed, in addition to negative results obtained in the bronchial provocation tests: a complete report from personal physician on medical history, including reports on hospital emergency department attendance or admission for acute exacerbations of asthma and on previous treatment with different medications, including systemic corticosteroids, and any additional information that might be helpful for the diagnosis.

Athletes who have questions regarding these changes to the IAAF Protocol are encouraged to contact USADA's Camila Zardo at 719-785-2045 as they begin the application process or the application renewal process.

Latest News

Anti-Doping Website Upgraded

The anti-doping section of the IAAF website has recently undergone a small upgrade, designed to make it easier for you to navigate, and quicker to locate the key information about the IAAF doping control program -

Among the latest additions to the site is a new "statistics" section which provides figures from the IAAF doping control program, as well as a list of anti-doping rule violations in 2005. These statistics will be continually updated and more information added in the near future. The addition of the statistics section is in line with the IAAF's commitment to increase the transparency of its doping control program

If you have any suggestions for the improvement of the site, or some information you believe is missing, please contact the IAAF Medical & Anti-Doping Department by email on

Reminder to Athletes in the USADA Out of Competition Testing Pool

Athlete Location Forms are due to USADA on March 1 for the 2nd quarter of 2006. If you have a question about your status in the USADA OOC Pool, please contact USATF's Melissa Beasley at 317-713-4650.

Athletes can submit forms electronically ( or via fax (719-785-2099). Forms can also be mailed to USADA at 1330 Quail Lake Loop, Suite 260, Colorado Springs, CO 80906.

USATF recommends that athletes always keep a copy of their quarterly athlete location form after they have submitted it to USADA for their personal records.

Athletes Advantage

Get your advantage with USADA's Athlete's Advantage program, which provides tools and resources to athletes more easily comply with anti-doping rules and policies.

The Athlete's Advantage Toolkit is a handy three-ring calendar binder containing important USADA publications, and is available to athletes in the Out-of-Competition (OOC) testing program. USADA launched the Athlete's Advantage Online to help athletes in the OOC testing program to learn how and where to access anti-doping resources. Athletes in the OOC testing program can sign up to receive the Toolkit while going through the online project, by e-mailing or calling (866) 601-2632 x 2044 or 719-785-2044. USADA publications are available to all athletes.

Get your advantage now by visiting For information about permitted and prohibited medications, use USADA's Drug Reference Online -, or call the Drug Reference Line at (800) 233-0393.

WADA Introduces Doping Quiz - Test your Knowledge

WADA has announced the launch of their new Doping Quiz, an online interactive tool to educate athletes about the dangers and consequences of doping.

The Doping Quiz, an integral part of WADA's Athlete Outreach Program (as seen at the 2005 Helsinki World Championships), can be played in nine different languages, including English, French, Spanish, Italian, German, Greek, Chinese, Portuguese, and Russian.

Test your knowledge about the fight against doping in sport and play the Doping Quiz.

2006 WADA Prohibited Substances List Effective 1/1/06

The World Anti-Doping Agency (WADA) 2006 Prohibited List will go into effect on January 1, 2006. Below are some of the key changes that may affect you directly. For the complete list, please go to

Substances and Methods Prohibited at All Times (In- and Out-of Competition)

S1. Anabolic Agents

1. Anabolic androgenic steroids

a. Exogenous
Desoxymethyltestosterone (designer steroid), methasterone, prostanozol and methyl-1-testosterone are added to the list of examples.

b. Endogenous
As described in the Explanatory Note of the 2005 List, that an Adverse Analytical Finding for 19-norandrosterone reported by a laboratory is sufficient proof and does not require further follow-up tests.

S5. Diuretics

Clarifies that drosperinone, a progestative with mild diuretic properties, is not prohibited (as indicated in the Explanatory Note of the 2005 Prohibited List).

Substances and Methods Prohibited In-Competition

S6. Stimulants

Adrenaline, which previously was exemplified in a footnote only, is now clearly named in the list of stimulants.

Some stimulants considered prohibited but not previously listed as examples in the 2004 and 2005 List, are re-introduced to the list of examples for clarification. Therefore, cropropamide, crotetamide, etamivan, heptaminol, isometheptene, and the isomers of methylamphetamine (levmethamfetamine, methamphetamine (D-), p- methamphetamine, ortetamine, phenpromethamine, propylhexedrine) are re-introduced as examples.

New examples of stimulants are added based on chemical structure or biological effect(s): cyclazodone, fenbutrazate, meclofenoxate, norfenefrine, octopamine, oxilofrine, pentetrazol, sibutramine.

S9. Glucocorticosteroids

Topical preparations, to treat aural/otic, nasal, buccal cavity and ophthalmic ailments, no longer require a Therapeutic Use Exemption due to a wide medical use and the absence of doping potential for these routes of administration.

2006 USADA Wallet Cards Are Now Available

USADA recently posted the 2006 USADA/WADA Prohibited Substances and Prohibited Methods Wallet Card online for athletes, coaches and trainers to download and print for reference. The Wallet Cards will also be available at various Visa Championship Series Events throughout the indoor and outdoor season.

Visit the USADA website for the updated Wallet Cards (PDF).

Please note that the list online is not complete and is subject to change. USATF recommends that athletes call the USADA Drug Reference line with questions about medications not listed on the Wallet Card at 1-800-233-0393.

Upcoming U.S. Events

February 3 Millrose Games, New York City, NY
February 11 Tyson Invitational, Fayetteville, AR
February 18-19 USA Cross Country Championships, New York City, NY
February 24-26 AT&T USA Indoor Track & Field Championships, Boston, MA
March 4-5 USA Indoor Combined Events Championships, Chapel Hill, NC
March 10-12 IAAF World Indoor Championships, Moscow, RUS
April 1-2 IAAF World Cross Country Championships, Fukuoka, JPN

Did You Know?

USA Track & Field has recently updated our in-house phone system, and all staff members now have a direct-dial number. Please visit our online organizational directory to see the numbers of USATF staff members you call regularly so you can update your records to reflect the new direct-dial numbers.

Important Numbers

  • USADA Drug Reference Line - 800-233-0393 (toll free)
  • USATF Whistleblower Hotline - 866-809-8104 (toll free)
  • USATF Anti-Doping Liaison (Melissa Beasley) - 317-713-4650

Links to other Anti-Doping Websites

Nike Visa BMW Gatorade Gill Athletics St. Vincent Lynx